<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>                               NIH Public Access <br />                                Author Manuscript <br />                                Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                            Published final edited form as: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                             Nat Struct Mol Biol. 2010 May ; 17(5): . doi:10.1038/nsmb.1810. <br />  <br />  <br />  <br />                            Cricket Paralysis Virus (CrPV) antagonizes Argonaute 2 <span id='am-5' about='protege:TO' typeof='owl:Thing'>to</span> <br />                            modulate antiviral defense Drosophila <br />                            Arabinda Nayak1, Bassam Berry2, Michel Tassetto1, Mark Kunitomi1, Ashley Acevedo1, <br />                            Changhui Deng3, Andrew Kruchinsky3, John Gross3, Christophe Antoniewski2, Raul <br />                            Andino1,* <br />                            1Department Microbiology Immunology, University California, San Francisco <br />  <br />                            94122-2280, USA <br />                            2Institut   Pasteur, Drosophila Genetics Epigenetics; CNRS, URA 2578, F-75015 Paris, France <br />                            3Department       Pharmaceutical Chemistry, University California, San Francisco 94122-2280, <br />                            USA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                            <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />                                  Insect viruses evolved strategies control host RNAi antiviral defense mechanism. In <br />                                  nature Drosophila C Virus (DCV) infection causes low mortality persistent infection, whereas <br />                                  closely related Cricket Paralysis Virus (CrPV) causes lethal infection. We viruses <br />                                  use different strategies modulate host RNAi defense machinery. The DCV RNAi suppressor <br />                                  (DCV-1A) binds long double-stranded RNA (dsRNA) prevents processing Dicer2. In <br />                                  contrast, CrPV suppressor (CrPV-1A) interacts endonuclease Ago2 inhibits its <br />                                  activity, affecting miRNA-Ago1 mediated silencing. The link viral RNAi <br />                                  suppressors outcome infection examined using recombinant Sindbis viruses <br />                                  encoding CrPV-1A DCV-1A. Flies infected Sindbis virus expressing CrPV-1A <br />                                  showed dramatic increase virus production, spread mortality. In contrast, Sindbis <br />                                  pathogenesis modestly increased expression DCV- 1A. We conclude RNAi <br />                                  suppressors function virulence factors. <br />  <br />  <br />                            Keywords <br />                                  viral defense; Drosophila C virus; Cricket Paralysis virus; RNAi suppressor; acquired immunity; <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                  viral persistence <br />  <br />  <br />                            Introduction <br />                                              <span id='am-318' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-319' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-320' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-321' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-322' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-323' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-324' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-325' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-326' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-327' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-328' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-329' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-330' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-331' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-332' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-333' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-334' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-335' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-336' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-337' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-338' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-339' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-340' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-341' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-342' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-343' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-344' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-345' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-346' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-347' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-348' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-349' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-350' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-351' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-352' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-353' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-354' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-355' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-356' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-357' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-358' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-359' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-360' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-361' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-362' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-363' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-364' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-365' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-366' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-367' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-368' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-369' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-370' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-371' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-372' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-373' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-374' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-375' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-376' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-377' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-378' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-379' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-380' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-381' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-382' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-383' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-384' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-385' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-386' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-387' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-388' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-389' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-390' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-391' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-392' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-393' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-394' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-395' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span>RNA interference</span> (RNAi) highly conserved, post-transcriptional gene expression control <br />                                              mechanism involved number critical cellular processes1. In insects plants, RNAi <br />                                              functions major antiviral defense mechanism2. In Drosophila, Dicer2, class III dsRNA <br />                                              endonuclease, processes viral dsRNA structures small interfering RNAs (siRNAs). <br />                                              siRNAs assemble RNA induced silencing complex (RISC) serve guides the <br />  <br />  <br />                            * <br />                             Corresponding author, Raul Andino, raul.andino@ucsf.edu. <br />                            Author contributions <br />                            A.N. R.A. designed interpreted experiments; A.N. performed experiments; B.B. C.A. designed <br />                            performed IR[white], GFP/bantam sensor retrotransposon experiments flies; M.T. M.K. performed fly <br />                            injections; A.A. plasmid constructs; C.D. A.K. carried mass spectrometry analysis; J.G. advised project. <br />                            A.N., R.A., A.A. C.A. prepared manuscript. <br />                             Nayak et al.                                                                                             Page 2 <br />  <br />  <br />                                           endonuclease Ago2, targets viral RNA degradation. As countermeasure to <br />                                           RNAi antiviral defense, viruses encode suppressors RNA silencing (VSR) modulate <br />                                           host antiviral response. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           The study viral RNAi suppressors provided insights mechanistic details of <br />                                           siRNA miRNA (microRNA) production, RISC assembly. A number of <br />                                           factors including helicases, double-stranded RNA binding proteins, endonucleases are <br />                                           required proper assembly functional RISC3,4. Accordingly, viral suppressors can <br />                                           potentially target factors circumvent host RNAi defense. Intriguingly, <br />                                           RNAi suppressors RNA binding proteins interact dsRNA precursors and/ <br />                                           siRNAs inhibit dsRNA processing Dicer assembly RISC5. However, some <br />                                           plant viral RNAi suppressors target components RNAi machinery itself. For <br />                                           instance, P0 suppressor protein plant polerovirus inhibits downstream events RISC <br />                                           assembly promoting Ago1 degradation6&#226;&#8364;&#8220;8. Another plant virus RNAi suppressor, <br />                                           Cucumber mosaic virus (CMV) 2b, inhibits siRNA miRNA pathway blocking <br />                                           Ago1 cleavage activity9. Furthermore, inhibition RNA silencing plant viral <br />                                           suppressors affects miRNA function, causing developmental abnormalities may <br />                                           contribute pathogenic consequences infection9,10. <br />  <br />                                           Several insect viruses encode RNAi suppressors2,11. Drosophila C virus (DCV) a <br />                                           positive strand RNA virus Dicistroviridae family infects strains D. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           melanogaster nature establishes non-lethal persistent infection12&#226;&#8364;&#8220;17. A closely <br />                                           related dicistrovirus, Cricket paralysis virus (CrPV), however, produces lethal infections in <br />                                           field crickets18 fruit fly19. The viral RNA genomes comprised distinct <br />                                           open reading frames, termed ORF1 ORF2, expression determined by <br />                                           internal ribosome entry site (IRES)-mediated translation initiation20. ORF1 encodes the <br />                                           non-structural replication proteins ORF2 encodes structural proteins form the <br />                                           viral capsid. Experimental infection DCV CrPV dramatically exacerbated flies <br />                                           genetic defects lacking RNAi effector proteins Dicer2 Ago2, indicating that <br />                                           RNAi bona fide anti-viral defense mechanism insects21&#226;&#8364;&#8220;23. The differential <br />                                           outcomes DCV CrPV infections nature, led examine closely <br />                                           related viruses employ distinct strategies control host antiviral response. We <br />                                           previously reported DCV encodes dsRNA binding protein, DCV-1A, suppresses <br />                                           RNA silencing specifically blocking Dicer2 processing virus dsRNA siRNAs22. <br />                                           On hand, mechanism employed CrPV counteract Drosophila immune <br />                                           established. <br />  <br />                                           Here CrPV encodes potent VSR, CrPV-1A interacts Ago2 and <br />                                           inhibits RISC activity. Furthermore, unlike plant virus RNAi suppressors, hitherto <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           undescribed RNAi inhibitor affects miRNA pathway alters normal <br />                                           development physiology animal. Given distinct pathogenic outcomes <br />                                           observed DCV CrPV infections nature, hypothesized RNAi suppressors <br />                                           function virulence factors. Indeed, CrPV DCV RNAi suppressor <br />                                           modulate outcome Sindbis virus infection flies. Recombinant Sindbis virus <br />                                           expressing CrPV-1A increases virus production resulting high mortality, whereas <br />                                           DCV-1A expression resulted modest enhancement infection. We propose that <br />                                           insect virus RNAi suppressors key modulators host immune response fine- <br />                                           tune outcome infection line evolutionary viral strategy successful host <br />                                           transmission. <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                            Page 3 <br />  <br />  <br />                               Results <br />                               CrPV infection blocks RNAi S2 cells <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Drosophila melanogaster deficient key RNAi endonucleases, Dicer2 Ago2, highly <br />                                           susceptible CrPV infection suggesting fly RNAi machinery plays essential role <br />                                           antiviral defense21&#226;&#8364;&#8220;23. Therefore, examined possibility CrPV encode a <br />                                           suppressor RNAi control RNA silencing machinery. RNAi suppression was <br />                                           analyzed S2 cells using dual luciferase reporter consisting firefly luciferase <br />                                           (FLuc) expressing plasmid specific 200 nt dsRNA targeting firefly luciferase <br />                                           mRNA eGFP dsRNA control (Ctrl) (Fig. 1a)22. Drosophila S2 cells CrPV <br />                                           mock infected 24 hour prior co-transfection reporter RNAi <br />                                           silencing activity. An internal control using renilla luciferase (RLuc) included in <br />                                           experiment. In uninfected control cells, observed efficient silencing firefly <br />                                           luciferase (suppression factor 380) compared control dsRNA. In contrast, <br />                                           silencing completely suppressed CrPV infected cells (Fig. 1a), indicating CrPV <br />                                           encodes potent suppressor RNAi. <br />  <br />                               The N-terminal region CrPV ORF1 encodes RNAi suppressor protein <br />                                           DCV CrPV closely related species cripavirus genus Dicistroviridae <br />                                           family. Amino acid sequence alignment DCV CrPV indicated high degree <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           (ca. 55%) identity open reading frame 1 (ORF1). A dsRNA binding motif (DSRM) <br />                                           previously identified N-terminal 99 amino acid region DCV ORF1, <br />                                           spanning residues 25&#226;&#8364;&#8220;88, shown encode potent suppressor RNAi (DCV-1A)22. <br />                                           Based observations, set determine suppression RNAi by <br />                                           CrPV attributed DCV-1A-like RNAi suppressor mapped N-terminus <br />                                           CrPV ORF1. <br />  <br />                                           Alignment DCV CrPV region revealed substantial homology compared <br />                                           homologous downstream amino acid sequences, includes highly conserved <br />                                           octamer sequence DVExNPGP (Fig. 1b). This octamer sequence serves signal co- <br />                                           translational protein cleavage glycine proline residues several <br />                                           picornaviruses24. We hypothesized DVExNPGP sequence serve similar <br />                                           function DCV CrPV polyprotein processing. We previously reported DSRM <br />                                           sequences upstream DVExNPGP site functions potent RNAi <br />                                           suppressor protein DCV22. We detected protein molecular weight consistent <br />                                           cleavage DVExNPGP site CrPV infected cells western blot analysis using a <br />                                           polyclonal antibody raised 148 N-terminal amino acids CrPV ORF1 (Fig. <br />                                           1c). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Next, evaluated ability CrPV sequence upstream DVExNPGP motif to <br />                                           suppress RNAi S2 cells. Using dual reporter assay, luciferase (Fluc, Rluc) expression <br />                                           plasmids co-transfected dsRNA specifically targets firefly luciferase and <br />                                           plasmids encoding C-terminal deletions putative CrPV RNAi suppressor protein (N- <br />                                           terminal 168, 148, 128, 108 amino acids). Both CrPV-1A168 CrPV-1A148 <br />                                           efficiently blocked RNA silencing (Fig.1d). In contrast, CrPV-1A128 CrPV-1A108 <br />                                           expression unable suppress RNAi (Fig.1d). Hence, N-terminal 148 amino acids <br />                                           CrPV ORF1 sufficient block RNAi S2 cells. To examine effects CrPV-1A <br />                                           suppressor vivo, generated transgenic flies expressing CrPV-1A148 protein, the <br />                                           inactive CrPV-1A108 fragment, GFP. In order monitor effects CrPV-1A148 <br />                                           suppressor vivo, transgenic flies crossed flies expressing hairpin <br />                                           dsRNA (inverted repeat) targeting white gene (IR[white]). The expression mini <br />                                           white genes suppressed expression hairpin dsRNA, providing a <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                            Page 4 <br />  <br />  <br />                                           colorimetric readout RNA silencing. The white gene efficiently silenced flies <br />                                           expressing GFP IR[white] hairpin causing orange eye color loss red <br />                                           eye pigmentation (Fig. 2a). In contrast, RNA silencing suppressed flies expressing <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           CrPV-1A148, resulting expression white gene and, thus, red eye color. Flies <br />                                           expressing inactive CrPV-1A108 able suppress white gene similar the <br />                                           GFP flies (Fig. 2a). Therefore, observations demonstrate CrPV-1A148 potent <br />                                           RNAi suppressor Drosophila. <br />  <br />                                           To characterize CrPV-1A148 (herein named CrPV-1A) suppressor, compared its <br />                                           RNAi suppressing efficiency RNAi suppressor DCV, DCV-1A99 (herein <br />                                           named DCV-1A). Suppression CrPV-1A DCV-1A assessed transgenic flies <br />                                           measuring accumulation red eye pigments flies expressing RNAi <br />                                           suppressor proteins control identical promoters (Fig. 2a). The red eye pigment <br />                                           absorbance (OD480) control flies expressing GFP IR[white] defined 100% <br />                                           silencing, OD480 value flies expressing IR[white] (Fig. 2a, Fig. 1A148 -) <br />                                           defined maximum inhibition silencing. Flies expressing CrPV-1A and <br />                                           IR[white] strongly inhibited RNA silencing (14% silencing) restored red eye <br />                                           <span id='am-84' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-85' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-87' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-90' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-91' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-94' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-96' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-97' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-100' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-102' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-105' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-107' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-108' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-109' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-110' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-111' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-112' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-114' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-117' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-119' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-125' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-129' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-130' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-131' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-135' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-141' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-143' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-144' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-147' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-150' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-154' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-157' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-160' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-161' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span>phenotype</span>, DCV-1A expression resulted modest effect RNA silencing (50% <br />                                           silencing) (Fig. 2a, compare 1A148 DCV-1A). Control flies expressing CrPV-1A108 <br />                                           GFP exhibited maximum silencing induced dsRNA hairpin targeting white gene <br />                                           (Fig. 2a). Western blot analysis demonstrated suppressor protein accumulated to <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           similar levels (Supplementary Fig. 1a). Furthermore, pathogenic effect DCV infection <br />                                           exacerbated expression CrPV-1A resulting higher mortality compared to <br />                                           transgenic flies expressing DCV-1A (Fig. 2b). Together, data indicate CrPV-1A is <br />                                           potent RNAi suppressor DCV-1A. <br />  <br />                               CrPV-1A inhibits siRNA function miRNA pathway <br />                                           In plants, VSR interfere miRNA pathway associated with <br />                                           disease symptoms resembling plant developmental defects25. We, thus, examined whether <br />                                           CrPV-1A inhibits Drosophila miRNA pathway. We carried experiments S2 <br />                                           cells using firefly luciferase reporter containing perfect complementary miR2b <br />                                           sequences (antisense) 3&apos; untranslated region (UTR)22(Supplementary Fig. 1b). 4A <br />                                           firefly luciferase mRNA containing copies miR2b sequence opposite <br />                                           orientation (sense) used control. S2 cells co-transfected firefly luciferase <br />                                           miR2b reporter constructs (sense antisense), plasmid encoding Renilla luciferase <br />                                           (transfection control), CrPV-1A DCV-1A expressing construct. The ratio of <br />                                           luciferase (miR2b antisense/miR2b sense) expression identical cells transfected with <br />                                           DCV-1A, CrPV-1A, vector, plasmid control (Fig. 2c). The dynamic range of <br />                                           miR2b reporter assay determined using anti-sense oligos (ASO) targeting <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           endogenous miR2b miRNA. ASO reduced miR2b silencing effect 50% compared to <br />                                           non-specific ASO control (Fig. 2d). We concluded CrPV-1A does affect miRNA <br />                                           gene silencing pathway S2 cells. <br />  <br />                                           The effect CrPV-1A miRNA pathway examined instar larvae. <br />                                           Transgenic flies expressing CrPV-1A crossed transgenic flies containing bantam <br />                                           miRNA sensor construct allows vivo imaging bantam miRNA activity26. A GFP <br />                                           reporter containing copies perfect bantam target sequence 3&#226;&#8364;&#8482;UTR was <br />                                           expressed control tubulin promoter (Supplementary Fig. 1c). Since bantam <br />                                           miRNA expression temporally spatially regulated response patterning cues, the <br />                                           expression GFP similar control characteristic GFP expression <br />                                           <span id='am-396' about='xsp:pattern' typeof='owl:Thing'>pattern</span> observed wing imaginal discs transgenic larvae (Fig. 2e, GFP/bantam). <br />                                           In contrast, GFP transgene construct lacking bantam target sequences showed <br />                                           ubiquitous GFP expression wing imaginal discs (Fig. 2e, GFP). To monitor effects of <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                           Page 5 <br />  <br />  <br />                                           CrPV-1A bantam, used engrailed-GAL4 driver express CrPV-1A the <br />                                           posterior compartment imaginal discs27. No effect observed bantam miRNA- <br />                                           mediated GFP repression presence CrPV-1A (Fig. 2e, GFP/bantam + CrPV-1A, <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Supplementary Serial Optical Sections 1 2). Additionally, ubiquitous expression of <br />                                           CrPV-1A development does generate defect adult flies, further <br />                                           suggesting CrPV-1A does affect miRNA pathway intact animal (not shown). <br />                                           Thus, unlike plant virus RNAi suppressors, CrPV-1A does interfere host <br />                                           miRNA pathway. <br />  <br />                                           Recently new class small RNA called endogenous small interfering RNA (esiRNAs) <br />                                           described Drosophila28&#226;&#8364;&#8220;30. The esiRNAs derive repetitive sequence <br />                                           elements like retrotransposons control replication somatic cells. To examine <br />                                           CrPV-1A perturbs esiRNA pathway, steady state level distinct <br />                                           retrotransposons 297, mdg1, 41228,29 analyzed female adult head transgenic flies <br />                                           expressing functional RNAi suppressor CrPV-1A148, DCV-1A99 control flies <br />                                           expressing non-functional suppressor CrPV-1A108, dsRNA binding mutant DCV-1A- <br />                                           K73A22. Homozygous Ago2414 mutant flies used positive control51 (Fig. 2f). <br />                                           Expression suppressor DCV-1A CrPV-1A, suppressor mutant controls <br />                                           significantly increased retrotransposon expression levels, indicating virus <br />                                           suppressors inhibit esiRNA pathway. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               The CrPV-1A blocks Ago2 cleavage activity <br />                                           We examined mechanism CrPV-1A inhibits RNAi. Since RNAi <br />                                           suppressors bind dsRNA inhibit silencing5, determined CrPV-1A binds <br />                                           dsRNA. Electrophoretic mobility shift experiments performed using radio-labeled <br />                                           dsRNA (200 bp) siRNA (21 bp) probes purified recombinant CrPV-1A DCV-1A <br />                                           (Supplementary Fig. 2a). Consistent previous findings22 DCV-1A efficiently <br />                                           bound long dsRNA (Supplementary Fig. 2a, lane 1, left panel) lesser extent to <br />                                           siRNA (lane 1, right panel). In contrast, CrPV-1A did bind dsRNA siRNA <br />                                           (Supplementary Fig. 2a, lanes 2&#226;&#8364;&#8220;7 9&#226;&#8364;&#8220;14). Next, examined effect CrPV-1A on <br />                                           Dicer2 activity using vitro assay. In S2 cell extracts, dsRNA efficiently processed <br />                                           21 bp siRNAs (Fig. 3a, lane 2). Production siRNA inhibited addition of <br />                                           recombinant DCV-1A (Fig. 3a, lane 5), recombinant CrPV-1A BSA control <br />                                           (Fig. 3a, lane 3 4). These experiments indicated CrPV-1A inhibits RNAi a <br />                                           different step DCV-1A, functioning downstream siRNA production. Indeed, <br />                                           CrPV-1A, unlike DCV-1A, effectively blocked silencing induced transfection both <br />                                           long dsRNA S2 cells 21bp siRNA (Supplementary Fig. 2b), supporting role <br />                                           downstream siRNA production. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           siRNAs produced Dicer2 incorporated RISC guide mRNA cleavage. Three <br />                                           siRNA nucleoprotein (siRNP) complexes occurring assembly process be <br />                                           resolved native gel electrophoresis, including initiator R1 (R2D2-Dcr2 initiator <br />                                           complex/RDI), intermediate R2 (RISC loading complex/RLC), effector R3 (holo- <br />                                           RISC) complex31&#226;&#8364;&#8220;33. We employed native gel analysis examine CrPV-1A <br />                                           affects RISC assembly. Incubation radio-labeled siRNA duplex Drosophila embryo <br />                                           extract resulted formation R1, R2 R3 complexes (Fig. 3b, lane 1). The presence of <br />                                           CrPV-1A did affect assembly complexes (Fig. 3b, lane 3). In contrast, <br />                                           addition DCV-1A inhibited formation holo-RISC (Fig. 3b, lane 2), yielding two <br />                                           intermediate complexes (Fig. 3b, denoted asterisks). These experiments indicated that <br />                                           CrPV-1A does affect siRNA loading holo-RISC assembly. Furthermore, find <br />                                           DCV-1A hitherto undescribed function affecting RISC assembly, addition its <br />                                           previously described function bind long dsRNA, suggesting DCV-1A acts several <br />                                           levels inhibit RNAi function. <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                              Page 6 <br />  <br />  <br />                                           Next tested CrPV-1A affects RISC-mediated mRNA cleavage using vitro <br />                                           target cleavage assay (Fig. 3c)34. S2 extracts, programmed FLuc siRNA, non- <br />                                           specific control siRNA, incubated 592 nt radio-labeled cap FLuc mRNA <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           substrate. In control reactions, FLuc mRNA target efficiently cleaved (5&#194;&#180; product) in <br />                                           presence FLuc specific siRNA, expected (Fig. 3c, compare lane 3 lanes 1 <br />                                           2). While purified DCV-1A addition little effect target cleavage, FLuc mRNA <br />                                           cleavage strongly inhibited addition purified recombinant CrPV-1A (Fig. 3c, <br />                                           lane 6, 7 8 CrPV lanes 10, 11 DCV). Similarly, cleavage inhibited <br />                                           extracts CrPV-infected S2 cells (Fig. 3c, lane 4 5). These experiments <br />                                           demonstrate CrPV-1A suppresses RNAi inhibiting RISC activity affecting <br />                                           Dicer processing RISC assembly. <br />  <br />                               CrPV-1A interacts Ago2 <br />                                           We hypothesized CrPV-1A inhibits RISC activity associating more <br />                                           components holo-RISC. To examine possibility, CrPV-1A carrying C-terminal <br />                                           tandem affinity (Flag His) purification tag (CrPV-1A-3FH) immunoisolated <span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> <br />                                           S2 cells. Western blot analysis using Ago2 specific antibody revealed CrPV-1A co- <br />                                           immunoprecipitated Ago2 (Fig. 4a, lane 4, right panel). In contrast, antibody <br />                                           directed Ago1 did detect Ago1 association CrPV1A (Fig. 4a. lane 2, <br />                                           left panel), consistent results showing CrPV-1A does affect Ago1- <br />                                           dependent miRNA pathway. The Ago2 antibody used detected Ago2 forms 130 kDa <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           95 kDa (Obbard et al., 2006). It possible smaller form product partial <br />                                           proteolysis affinity tag purification, detect 95 kDa isoform (Fig 4b and <br />                                           Fig 4c). To analyze interaction CrPV-1A Ago2, transiently <br />                                           expressed CrPV-1A148-3FH CrPV-1A108-3FH S2 cells. While <span id='am-4' about='xsp:length' typeof='owl:Thing'>length</span> <br />                                           CrPV-1A148-3HF co-precipitated Ago2, truncated CrPV-1A108 unable to <br />                                           interact Ago2 (Fig 4b, lane 2). The interaction CrPV-1A Ago2 further <br />                                           analyzed two-step affinity purification S2 extracts stably expressing <br />                                           CrPV-1A148-3FH. Commassie staining purified materials revealed presence of <br />                                           distinct bands present control sample (Supplementary Fig. 3). Mass- <br />                                           spectroscopy analysis identified bands CrPV-1A Ago2. Furthermore, silver <br />                                           staining CrPV-1A associated proteins uncovered additional proteins (Fig. 4c, lane 2). <br />                                           These experiments suggested CrPV-1A blocks catalytic activity RISC direct <br />                                           interaction endonuclease Ago2. <br />  <br />                               CrPV-1A acts preassembled holo-RISC <br />                                           The observation CrPV-1A does affect siRNA-RISC assembly vitro (Fig. 3b), but <br />                                           nonetheless inhibits RISC cleavage activity (Fig. 3c), suggests CrPV-1A interferes with <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           function assembled holo-RISC. To directly test possibility luciferase mRNA <br />                                           target cleavage assay performed. S2 cell extracts pre-incubated duplex <br />                                           siRNA allow holo-RISC assembly31&#226;&#8364;&#8220;33 followed recombinant CrPV-1A addition. We <br />                                           observed CrPV-1A efficiently inhibited holo-RISC enzymatic activity after <br />                                           assembly holo-RISC (Fig. 5a, lane 3). As expected, DCV-1A BSA control no <br />                                           effect pre-assembled RISC cleavage (Fig. 5a, lanes 4 5). <br />  <br />                                           The ability CrPV-1A inhibit holo-RISC activity vivo examined using the <br />                                           dual-luciferase reporter S2 cells expressing CrPV-1A control an <br />                                           inducible metallothionein promoter (Fig 5b). Cells co-transfected plasmids <br />                                           expressing Renilla firefly luciferase dsRNA targeting firefly luciferase (dsLuc), or <br />                                           GFP (dsGFP) 16 hrs allow maximal silencing luciferase activity (Fig. 5b, <br />                                           dsLuc). Induction CrPV-1A expression 16 hrs resulted near-complete restoration of <br />                                           firefly luciferase expression (Fig. 5b, dsLuc + CrPV-1A) compared CrPV-1A <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                             Page 7 <br />  <br />  <br />                                           expression control (dsLuc). Together, results indicate CrPV-1A efficiently <br />                                           inhibit pre-assembled holo-RISC function. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Previous findings indicated that, Drosophila, Ago2 component active holo-RISC, <br />                                           sediments ribosomal fraction following high-speed centrifugation <br />                                           (200,000&#195;&#8212;g)35. To examine CrPV-1A associates active holo-RISC, <br />                                           cytoplasmic extracts CrPV-1A expressing S2 cells subjected high-speed <br />                                           centrifugation separate high molecular weight fraction (P200) supernatant (S200). <br />                                           Fractions analyzed immunoblot using antibodies specifically recognize Ago2 <br />                                           CrPV-1A. Expression CrPV-1A did affect distribution Ago2 the <br />                                           S200 P200 fractions (Fig. 5d, &#206;&#177;-Ago2). Furthermore, CrPV-1A expression did affect <br />                                           siRNA association P200 fraction (Fig. 5d, northern blot, compare lanes 1, 2). <br />                                           Interestingly, CrPV-1A fractionates preferentially high molecular weight P200 <br />                                           fraction, despite fact purified recombinant CrPV-1A migrates smaller soluble <br />                                           protein gel filtration analysis (data shown). We concluded CrPV-1A neither <br />                                           induces Ago2 degradation causes disassembly holo-RISC, instead specifically <br />                                           recruited holo-RISC containing P200 fraction, exerts inhibitory effect <br />                                           binding Ago2. <br />  <br />                               RNAi suppressors virulence determinants <br />                                           It puzzling viruses overall homology CrPV DCV exhibit <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           dramatically different virulence levels natural infection12,13,18,19. Both DCV CrPV <br />                                           induce high mortality fruit flies intra-thoracic injection experimental laboratory <br />                                           condition21,22. In contrast, DCV causes mild persistent infection CrPV infection <br />                                           highly lethal oral inoculation 13,14,16,19,36,37. Furthermore S2 cells, DCV <br />                                           establishes persistent infection following initial acute phase, CrPV highly lytic <br />                                           establishment persistent infection (data shown). <br />  <br />                                           Virus pathogenesis determined factors, including ability virus evade <br />                                           host immune response. Given different properties suppressor, considered <br />                                           determine outcome infection. Ideally, hypothesis be <br />                                           tested engineering virus carrying different RNAi suppressors an <br />                                           isogenic backgrounds. Given infectious clones available either <br />                                           DCV CrPV, examined effect CrPV-1A DCV-1A context a <br />                                           recombinant Sindbis virus infection. We engineered recombinant Sindbis viruses express <br />                                           green fluorescent protein (GFP) RNAi suppressors CrPV-1A (Sin-CrPV148) or <br />                                           DCV-1A (Sin-DCV99) control duplicated sub-genomic promoter (Fig. 6a)15. <br />                                           Control Sindbis viruses expressed inactive suppressors -- truncated version CrPV-1A <br />                                           (Sin-CrPV108) DCV-1A carrying <span id='am-240' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-241' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-242' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-243' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-244' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-245' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-246' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-247' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-248' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-249' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-250' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-251' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-252' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-253' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-254' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-255' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-256' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-257' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-258' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-259' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-260' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-261' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-262' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-263' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-264' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-265' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-266' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-267' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-268' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-269' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-270' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-271' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-272' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-273' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-274' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-275' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-276' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-277' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-278' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-279' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-280' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-281' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-282' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-283' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-284' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-285' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-286' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-287' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-288' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-289' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-290' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-291' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-292' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-293' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-294' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-295' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-296' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-297' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-298' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-299' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-300' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-301' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-302' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-303' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-304' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-305' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-306' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-307' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-308' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-309' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-310' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-311' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-312' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-313' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-314' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-315' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-316' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-317' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span>mutation</span> DSRM (Sin-DCVK73A)22. In <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           addition infecting insect cells, Sindbis infects mammalian cells, appear <br />                                           use RNAi control virus, affording unbiased control viral replication <br />                                           efficiency. No appreciable differences virus replication kinetics observed these <br />                                           recombinant viruses mammalian BHK-21 cells (Fig. 6b), indicating expression of <br />                                           RNAi suppressors does affect virus fitness cells RNAi machinery does not <br />                                           play major role antiviral defense38. <br />  <br />                                           Sindbis virus does appear encode RNAi suppressor (data shown) and <br />                                           establishes persistent infection Drosophila39. We determined effect of <br />                                           CrPV-1A DCV-1A Sindbis infection following intra-thorax inoculations in <br />                                           Drosophila. Both Sin-CrPV148 Sin-DCV99 increased fly mortality compared the <br />                                           control virus expressing inactive suppressor, Sin-CrPV108 (Fig. 6c). Consistent the <br />                                           observation CrPV-1A effective RNAi suppressor DCV-1A (Fig. 2a and <br />                                           2b), Sin-CrPV148 induced higher mortality flies Sin-DCV99 (Fig. 6c). This <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                               Page 8 <br />  <br />  <br />                                           enhanced pathogenicity correlated dramatic increase virus replication (Fig. 6d, &#206;&#177;&#226;&#8364;&#8220; <br />                                           GFP fluorescence AU). Strikingly, Sin-CrPV148 infection generated broader GFP <br />                                           tissue distribution seen thorax, abdomen, head, legs injected flies (Fig. 6d, i). <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Infection control Sin-CrPV108 caused localized GFP expression site of <br />                                           injection, suggesting absence functional suppressor limits infectivity (Fig. <br />                                           6d, ii) virus spread (Fig. 6d, i). We measured modest increase GFP expression <br />                                           Sin-DCV99 infection localized predominately thorax, lesser <br />                                           extent head injected flies (Fig. 6d, ii). Quantification GFP expression western <br />                                           blot fluorescence microscopy demonstrated GFP expression approximately 5 <br />                                           fold higher flies infected Sin-CrPV148 compared Sin-DCV99 (Fig.6d, &#206;&#177;&#226;&#8364;&#8220;GFP <br />                                           Fluorescence AU). GFP expression steadily increased 10 days post Sin- <br />                                           CrPV148 infection, point GFP levels remained constant (data shown). <br />                                           Importantly, infected flies exhibited maximum GFP expression 10 days post Sin-DCV99 <br />                                           infection followed gradual reduction fluorescence, suggesting flies able to <br />                                           control infection. We observed striking correlation enhancement of <br />                                           Sindbis infection severity CrPV-1A, potency suppressor, virulence of <br />                                           natural CrPV infections. In contrast, DCV, produces moderate natural infection, <br />                                           carries suppressor causes modest increase Sindbis virulence. Taken together, these <br />                                           results indicated distinctly acting RNAi suppressors virulence factors that <br />                                           determine outcome infection. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Discussion <br />                                           RNA interference (RNAi) provide sequence specific antiviral immunity plants and <br />                                           insects40&#226;&#8364;&#8220;42. To counteract antiviral mechanism, viruses evolved suppressor <br />                                           proteins RNAi-modulating activity. We identified unique mode action <br />                                           employed CrPV suppressing RNAi-based antiviral immunity. This suppression <br />                                           activity mapped N-terminal region CrPV ORF1, encoding protein CrPV-1A. <br />                                           We CrPV-1A specifically interacts Ago2 context preassembled holo- <br />                                           RISC potently suppress RNAi Drosophila. <br />  <br />                                           The mechanism CrPV-1A different RNAi suppressors FHV (B2) DCV <br />                                           (1A), appear prevent viral dsRNA processing Dicer 2 siRNAs assemble <br />                                           RISC 2,11. This widely used strategy presumably relies physical shielding viral <br />                                           dsRNAs RNAi machinery. In contrast, CrPV-1A, shows detectable RNA <br />                                           binding affinity (Supplementary Fig. 2) does prevent loading siRNAs (Fig. <br />                                           3b, Fig. 5d) formation holo-RISC (Fig. 3b, Fig. 5d). We CrPV-1A <br />                                           interacts Ago2 (Fig 4c) inhibits RISC activity vivo vitro affecting <br />                                           Dicer processing RISC assembly (Fig. 3&#226;&#8364;&#8220;5). CrPV-1A, absence viral <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           proteins, preferentially recruited high molecular weight pre-assembled holo-RISC <br />                                           fractions containing Ago2 siRNAs (Fig. 5d), inhibits holo-RISC catalytic activity <br />                                           following RISC pre-formation assembly (Fig. 5a). In principle, additional CrPV-1A <br />                                           functions CrPV replication cycle excluded, given multifunctional <br />                                           nature viral proteins. However, fact CrPV-1A inhibits RNAi and <br />                                           suffices strongly enhance pathogenicity evolutionarily unrelated Sindbis virus <br />                                           demonstrates CrPV-1A itself RNAi suppressor autonomous pathogenesis <br />                                           modulating function, transferable viruses. <br />  <br />                                           While existence virus-encoded RNAi suppressors animals firmly <br />                                           documented, relatively little known factors intersect host functions <br />                                           contribute overall balance viral replication transmission. <br />                                           Comparison RNAi suppression strategies closely related viruses, DCV CrPV, <br />                                           yield insights issues. Notably, viruses specific host <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                             Page 9 <br />  <br />  <br />                                           siRNA pathway, CrPV-1A DCV-1A affected miRNA gene-silencing <br />                                           pathway (Fig. 2). Indeed, CrPV-1A suppresses siRNA-mediated gene-silencing pathway <br />                                           selectively interacting Ago2, related Ago1 homolog (Fig 4a) involved in <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           miRNA-mediated RISC function. Both DCV CrPV affect esiRNA mediated <br />                                           retrotransposons silencing virtue abilities counteracts functions Dicer2 <br />                                           Ago2 respectively (Fig 2f). These observations contrast known plant virus RNAi <br />                                           suppressors, discriminate siRNA miRNA pathways9,25,43. <br />                                           Due aberrations miRNA pathway infection, plant viruses cause <br />                                           physiological developmental abnormalities host9,25,43. The difference <br />                                           plant animal viruses explained interdependent nature plant <br />                                           siRNA miRNA pathways opposed distinctly separate pathways observed in <br />                                           Drosophila melanogaster3. Since miRNAs important host physiology and <br />                                           development, selectivity RNAi suppression insect viruses afford an <br />                                           evolutionary advantage. By controlling host RNAi antiviral response perturbing <br />                                           normal host physiology, viruses replicate efficiently establish persistent infection, <br />                                           facilitating vertical transmission virus host progeny. These strategies <br />                                           ensure virus transmission <span id='am-6' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-7' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-9' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-10' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-12' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-17' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-20' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-23' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-24' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-27' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-28' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-30' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-34' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-41' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-42' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-43' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-45' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-46' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-47' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-48' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-49' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-50' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-52' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-55' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-57' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-61' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-64' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-69' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-73' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-74' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-76' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-78' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-81' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-82' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-83' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span>survival</span> host population. <br />  <br />                                           DCV CrPV closely related viruses Dicistroviridae family. While both <br />                                           viruses encode RNAi suppressor N-terminus genomes, suppressors exhibit <br />                                           different mechanisms action RNAi suppressor potency. Our data suggests that <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           potency inhibition host antiviral defense contributes differential <br />                                           pathogenicity. Indeed, engineering Sindbis virus carry DCV-1A CrPV-1A altered the <br />                                           pathogenicity benign Sindbis infection flies acute varying <br />                                           severity. Since RNAi suppressors expressed site Sindbis <br />                                           virus, using promoter absence CrPV DCV proteins, these <br />                                           experiments provide direct readout link autonomous RNAi suppressor <br />                                           function pathogenicity. The expression potent RNAi suppressor, CrPV-1A, <br />                                           significantly enhanced Sindbis virus pathogenicity correlated dramatic increase in <br />                                           virus replication fly mortality. On hand Sin-DCV99 partially more <br />                                           pathogenic. It tempting speculate differential potency CrPV DCV <br />                                           RNAi suppressors stems different modes action. DCV-1A relies on <br />                                           nonspecific RNA binding activity protect long dsRNA Dicer2 processing. Complete <br />                                           RNAi inhibition likely requires high levels DCV-1A production saturate Dicer2 <br />                                           processing sites. In contrast, CrPV-1A acts directly inhibiting catalytic component of <br />                                           RISC (Fig. 5e), multi-turn enzyme44. Thus, inhibition siRISC CrPV-1A <br />                                           provide efficient strategy prevent viral genome degradation, lead <br />                                           high viral titer production. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           The differential potency RNAi suppressors DCV CrPV, differential <br />                                           effects Sindbis pathogenicity resonate different types infection caused by <br />                                           similar viruses. CrPV highly lytic virus induces substantial <br />                                           mortality flies19. In contrast, DCV, nature, establishes symbiotic, chronic infection in <br />                                           Drosophila causing appreciable mortality12,13,16,45. Indeed, DCV found <br />                                           field populations random screening flies result particular <br />                                           syndrome13. Given pathogenic characteristics DCV CrPV infection are <br />                                           replicated simply transferring respective RNAi suppressors Sindbis, argue that <br />                                           proteins attuned natural virus infection strategy. For instance, chronic, <br />                                           persistent infection Drosophila characterized DCV attributed modest <br />                                           RNAi suppressing activity exhibited DCV-1A. Our results point exquisite <br />                                           equilibrium host antiviral defense machinery viral RNAi suppressors <br />                                           serves evolutionary fine tune host-virus interactions determines the <br />                                           pathogenic outcome infection, virus survival, virus spread. <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                           Page 10 <br />  <br />  <br />                               Methods <br />                               RNAi reporter assay <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              We cultured Drosophila S2 cells (Supplementary Fig. 4), 96 plates. We transfected <br />                                              S2 cells plasmids encoding CrPV-1A infected CrPV (MOI 1) carried out <br />                                              RNAi reporter assay described22. We tested effect CrPV-1A microRNA <br />                                              (miRNA) miR2b function described22. We designed antisense oligonucleotides (ASO) <br />                                              endogenous miR2b46and transfected S2 cells using Dharmafect 4 reagent <br />                                              (Dharmacon) 48 hrs followed co-transfection reporter systems. We synthesized <br />                                              2&#226;&#8364;&#8482;-O-Me 3&#226;&#8364;&#8482; cholesterol modified miR-2b ASO <br />                                              (C.A.A.A.U.G.C.U.C.C.U.C.A.A.A.G.C.U.G.G.C.U.G.U.G.A.U.A.A.U.U.C.U.3&apos;-Chl) from <br />                                              Dharmacon. <br />  <br />                               Dicer assay <br />                                              We performed Dicer assay S2 cell extracts described22,34. We incubated recombinant <br />                                              DCV-1A, CrPV-1A BSA reaction 10 min followed addition uniformly <br />                                              labeled 200 bp GL3 dsRNA (105 cpm) 3 hrs 25&#194;&#176;C. <br />  <br />                               Slicer assay <br />                                              We performed RISC cleavage assays described33 using 5&#226;&#8364;&#8482; capped FLuc mRNA target <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              (592 nt) specific siRNA generates 100nt 5&#226;&#8364;&#8482; cleaved product. We used <br />                                              CrPV DCV infected S2 extract supplemented recombinant CrPV-1A DCV-1A in <br />                                              uninfected S2 extract. We performed 35 &#194;&#181;l reaction (40% v/v S2 extracts) 3hr 25&#194;&#176;C. <br />  <br />                               Assembly assay <br />                                              We performed RISC assembly experiments described31,32. We incubated recombinant <br />                                              suppressor protein embryo extract 10 min, subsequently added 32P-radiolabeled <br />                                              siRNA duplex reaction 20 min. The 5&#194;&#181;l reactions contained 40% v/v <br />                                              embryo lysates. <br />  <br />                               Generation stable S2 cell lines <br />                                              We cloned CrPV-1A frame C-terminal 3xFLAG 6xHis tags vector pMT/V5- <br />                                              HisA (Invitrogen). We generated stable cell lines according manufacturer&#226;&#8364;&#8482;s instruction <br />                                              (Invitrogen). We induced expression protein 500 &#194;&#181;M CuSO4 20 hrs. <br />  <br />                               Immunoprecipitation <br />                                              We transfected plasmids pAc-CrPV148-3FH, pAc-CrPV108-3FH, pAc5.1-V5/HisA vector <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              (Invitrogen) S2 cells (1&#195;&#8212;107 cells) 24 hour, resuspended cells IP buffer [30mM <br />                                              Hepes pH 7.4, 150mM KOAc, 2mM MgOAc, 5mM DTT, 0.1% NP-40, protease inhibitor <br />                                              tablet (Roche)] sonicated ice. We centrifuged (14,000&#195;&#8212;g) added supernatant to <br />                                              magnetic beads (Dynal) conjugated anti-Flag M2 antibody. We washed beads and <br />                                              boiled SDS sample buffer 95&#194;&#176;C 5 min. We ran eluted sample 4&#226;&#8364;&#8220;20% gradient <br />                                              SDS-PAGE gel, transferred PVDF membrane probed Drosophila Ago1 Ago2 <br />                                              antibodies. We followed purification profile western blot (Supplementary Fig. 5) <br />  <br />                               Suppressor-Argonaute 2 complex purification <br />                                              We resuspended grams induced uninduced stable S2 cells 1ml IP buffer <br />                                              ground powder mortar pestle liquid nitrogen. We prepared crude <br />                                              extracts adding 9ml IP buffer ground S2 cell homogenized 2 min ice. We <br />                                              centrifuged (14,000&#195;&#8212;g) added supernatant anti-Flag M2 antibody conjugated <br />  <br />  <br />                                              Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                           Page 11 <br />  <br />  <br />                                             magnetic beads (Invitrogen), washed IP buffer eluted using IP buffer 3X Flag <br />                                             peptide (400 &#194;&#181;g ml&#226;&#710;&#8217;1)(Sigma). We added eluted sample Talon magnetic beads <br />                                             (Invitrogen), washed IP buffer eluted IP buffer containing 250 mM Imidazole. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             We stained eluted material sliver according manufacturer&#226;&#8364;&#8482;s instruction (Invitrogen). <br />                                             To determine expression profile Ago2 CrPV-1A stable S2 cells followed <br />                                             step (Flag IP) purification protocol analyzed western blot analysis <br />                                             (Supplementary Fig. 5). <br />  <br />                               Protein Identification <br />                                             We resolved eluted sample 4&#226;&#8364;&#8220;20% gradient gel stained using coomassie brilliant <br />                                             blue (Sigma). We excised protein bands destanined followed gel trypsin digestion. <br />                                             We analyzed trypsin generated peptide fragments using modular mass spectrometric <br />                                             tool, includes MALDI-MS MALDI-MS/MS mass spectrometer as <br />                                             HPLC-MS/MS mass spectrometer47. <br />  <br />                               Expression purification recombinant proteins <br />                                             We cloned CrPV-1A pHis-Gb1-II vector48, transformed BL21DE3 cells and <br />                                             purified His-tag fusion protein using Ni-NTA resin (Qiagen). We purified GST-DCV-1A as <br />                                             described22. Polyclonal antibody CrPV-1A raised rabbits immunized with <br />                                             purified recombinant proteins. Expression full-length Drosophila Argonaute 1 E.coli <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                             carried described CrPV-1A. <br />  <br />                               RNAi Fly <br />                                             We established transgenic flies expressing CrPV-1A developing eye described22. We <br />                                             performed eye pigment determination assays 3 days virgin females49. We established <br />                                             microRNA sensor lines expressing CrPV-1A below. We recombined P[Tub-bantam <br />                                             sensor]26 transgenic stocks genetic crosses P[engrailed-Gal4] line27 obtain <br />                                             homozygous w1118 ; II P[engrailed-Gal4] ; III P[Tub-bantam sensor] miRNA bantam <br />                                             sensor line. We crossed homozygous P[pUAS-CrPV-148], P[pUAS-CrPV108] w1118 <br />                                             stocks sensor line. We dissected wing imaginal discs instar larvae fixed in <br />                                             4% formaldehyde, stained mouse monoclonal anti-GFP (Roche) visualize sensor <br />                                             expression using Apotome microscopy. To observe effect RNAi suppressors retro- <br />                                             transposons expression, transgenic flies expressing CrPV-1A described50. We <br />                                             measured expression levels 412, mdg1 297 transposon double heterozygous <br />                                             UASp&gt;VSR; da&gt;GAL4 control heterozygous da&gt;GAL4 2-days old females. We <br />                                             manually separated fifty heads processed total RNA extraction reverse <br />                                             transcription. We analyzed Transposon levels real-time PCR using primers described <br />                                             28,29,50. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                               Holo-RISC fractionation <br />                                             We transfected 20 &#194;&#181;g dsRNA (200 bp FLuc dsRNA) stable S2 cells (1&#195;&#8212;107) using <br />                                             Effectene reagent (Qiagen). After 48 hr, cells induced CuSO4 additional 20 <br />                                             hrs. We performed Holo-RISC purification described 35. We resuspended cells in <br />                                             hypotonic buffer (10 mM Hepes pH 7.4 6 mM &#206;&#178;-mercaptoethanol), lysed passing <br />                                             insulin syringe, spun 14,000&#195;&#8212;g 25 min 4&#194;&#176;C. We centrifuged post- <br />                                             nuclear, cytoplasmic extract 200,000 &#195;&#8212;g 3hrs 4&#194;&#176;C separate ribosomal pellet <br />                                             (P200) supernatant (S200). We probed P200 S200 fraction Argonaute 2 and <br />                                             CrPV-1A western blot. <br />  <br />  <br />  <br />  <br />                                             Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                                           Page 12 <br />  <br />  <br />                               Northern blotting <br />                                           We treated ribosomal pellet (P200) 1mM MgCl2 400mM KOAc. We centrifuged <br />                                           extracted soluble material 100,000&#195;&#8212;g 1 hr 4&#194;&#176;C. We treated supernatant with <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           SDS proteinase K extracted RNA phenol. We resolved small RNA 12% <br />                                           Urea-gel, transferred Hybond-N+ nylon membrane (Amersham Biosciences) and <br />                                           hybridized Fluc sense strand riboprobe. <br />  <br />                               Recombinant Sindbis virus production Fly injection <br />                                           We generated Sindbis virus expressing RNAi suppressor CrPV-1A DCV-1A as <br />                                           described15. We determined growth kinetics viruses BHK 21 cells. We injected five- <br />                                           day-old female flies thorax 50 nl virus (2500&#226;&#8364;&#8220;5000 PFU) using nanoinjector <br />                                           (Nanoject II, Drummond Scientific). We observed GFP expression flies GFP <br />                                           microscopy western blot analysis. We incorporated GFP images group flies (4&#226;&#8364;&#8220;5 <br />                                           each) Volocity software (Improvision, UK) measurement module. We <br />                                           used non-injected flies background calculation. To determine pathogenicity <br />                                           DCV transgenic flies expressing CrPV-1A DCV-1A, injected 100 TCID50 of <br />                                           DCV intra-thoracic injection described22. <br />  <br />                               Supplementary Material <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Refer Web version PubMed Central supplementary material. <br />  <br />  <br />                               Acknowledgments <br />                                           We thank Judith Frydman (Stanford University) member Andino laboratory Leonid Gitlin, Dwight <br />                                           Barnes, Michelle Flenniken Adam Lauring useful discussion preparing manuscript. Special thank to <br />                                           Ronald van Rij (Nijmegen Centre Molecular Life Sciences, Netherlands) Carla Saleh (Institut Pasteur, <br />                                           France) help. We thank Dr Graham Belsham (National Veterinary Institute, Denmark) critical reading <br />                                           manuscript useful comments. We grateful Phil Zamore (UMass Medical School), Mikiko Siomi <br />                                           Keita Miyoshi (Keio University School Medicine, Japan) providing antibody directed Drosophila <br />                                           Argonaute 2, Hans Heidner providing Sindbis virus plasmid (University Texas, San Antonio) Michelle <br />                                           Moritz (UCSF) Drosophila embryo extract preparation. This work financially supported Pasteur <br />                                           Institute, CNRS grants ANR (AKROSS) ARC C.A., NIH grants AI40085 and <br />                                           AI064738 R.A. <br />  <br />  <br />                               References <br />                                           1. Siomi H, Siomi MC. On road reading RNA-interference <span id='am-3' about='Thesaurus:code' typeof='owl:Thing'>code</span>. Nature. 2009; 457:396&#226;&#8364;&#8220; <br />                                              404. [PubMed: 19158785] <br />                                           2. van Rij RP, Andino R. The silent treatment: RNAi defense virus infection mammals. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              Trends Biotechnol. 2006; 24:186&#226;&#8364;&#8220;193. [PubMed: 16503061] <br />                                           3. Forstemann K, Horwich MD, Wee L, Tomari Y, Zamore PD. Drosophila microRNAs sorted into <br />                                              functionally distinct argonaute complexes production dicer-1. Cell. 2007; 130:287&#226;&#8364;&#8220;297. <br />                                              [PubMed: 17662943] <br />                                           4. Tomari Y, Du T, Zamore PD. Sorting Drosophila small silencing RNAs. Cell. 2007; 130:299&#226;&#8364;&#8220; <br />                                              308. [PubMed: 17662944] <br />                                           5. Ding SW, Voinnet O. Antiviral immunity directed small RNAs. Cell. 2007; 130:413&#226;&#8364;&#8220;426. <br />                                              [PubMed: 17693253] <br />                                           6. Baumberger N, Tsai CH, Lie M, Havecker E, Baulcombe DC. The Polerovirus silencing suppressor <br />                                              P0 targets ARGONAUTE proteins degradation. Curr Biol. 2007; 17:1609&#226;&#8364;&#8220;1614. [PubMed: <br />                                              17869110] <br />                                           7. Bortolamiol D, Pazhouhandeh M, Marrocco K, Genschik P, Ziegler-Graff V. The Polerovirus F box <br />                                              protein P0 targets ARGONAUTE1 suppress RNA silencing. Curr Biol. 2007; 17:1615&#226;&#8364;&#8220;1621. <br />                                              [PubMed: 17869109] <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                                  Page 13 <br />  <br />  <br />                                           8. Pazhouhandeh M, et al. F-box-like domain polerovirus protein P0 required silencing <br />                                              suppressor function. Proc Natl Acad Sci U S A. 2006; 103:1994&#226;&#8364;&#8220;1999. [PubMed: 16446454] <br />                                           9. Zhang X, et al. Cucumber mosaic virus-encoded 2b suppressor inhibits Arabidopsis Argonaute1 <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                              cleavage activity counter plant defense. Genes Dev. 2006; 20:3255&#226;&#8364;&#8220;3268. [PubMed: 17158744] <br />                                           10. Kasschau KD, et al. P1/HC-Pro, viral suppressor RNA silencing, interferes Arabidopsis <br />                                               development miRNA unction. Dev Cell. 2003; 4:205&#226;&#8364;&#8220;217. [PubMed: 12586064] <br />                                           11. Chao JA, et al. Dual modes RNA-silencing suppression Flock House virus protein B2. Nat <br />                                               Struct Mol Biol. 2005; 12:952&#226;&#8364;&#8220;957. [PubMed: 16228003] <br />                                           12. Gomariz-Zilber E, Thomas-Orillard M. Drosophila C virus Drosophila hosts: good <br />                                               association various environments. Journal Evolutionary Biology. 1993; 6:677&#226;&#8364;&#8220;689. <br />                                           13. Brun, P.; Plus, N. The Genetics Biology Drosophila. Vol. Vol 2d. New York: Academic <br />                                               Press; 1980. The viruses Drosophila; p. 625-702. <br />                                           14. Jousset F-X, Plus N. Etude la transmission horizontale et la transmission verticale de <br />                                               Picornavirus Drosophila melanogaster et Drosophila immigrans. Ann Microbiol (Inst <br />                                               Pasteur). 1975; 126:231&#226;&#8364;&#8220;249. <br />                                           15. Thomas JM, Klimstra WB, Ryman KD, Heidner HW. Sindbis virus vectors designed express a <br />                                               foreign protein cleavable component viral structural polyprotein. J Virol. 2003; <br />                                               77:5598&#226;&#8364;&#8220;5606. [PubMed: 12719552] <br />                                           16. Aravin AA, et al. The small RNA profile Drosophila melanogaster development. Dev Cell. <br />                                               2003; 5:337&#226;&#8364;&#8220;350. [PubMed: 12919683] <br />                                           17. Gomariz-Zilber E, Poras M, Thomas-Orillard M. Drosophila C virus: experimental study of <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               infectious yields underlying pathology Drosophila melanogaster laboratory populations. J <br />                                               Invertebr Pathol. 1995; 65:243&#226;&#8364;&#8220;247. [PubMed: 7745279] <br />                                           18. Reinganum C. The isolation cricket paralysis virus emperor gum moth, Antheraea <br />                                               eucalypti Scott, infectivity range insect species. Intervirology. 1975; 5:97&#226;&#8364;&#8220; <br />                                               102. [PubMed: 1184353] <br />                                           19. Manousis T, Moore NF. Cricket Paralysis Virus, Potential Control Agent Olive Fruit Fly, <br />                                               Dacus oleae Gmel. Appl Environ Microbiol. 1987; 53:142&#226;&#8364;&#8220;148. [PubMed: 16347255] <br />                                           20. Wilson JE, Powell MJ, Hoover SE, Sarnow P. Naturally occurring dicistronic cricket paralysis <br />                                               virus RNA regulated internal ribosome entry sites. Mol Cell Biol. 2000; 20:4990&#226;&#8364;&#8220;4999. <br />                                               [PubMed: 10866656] <br />                                           21. Galiana-Arnoux D, Dostert C, Schneemann A, Hoffmann JA, Imler JL. Essential function vivo <br />                                               Dicer-2 host defense RNA viruses drosophila. Nat Immunol. 2006; 7:590&#226;&#8364;&#8220;597. <br />                                               [PubMed: 16554838] <br />                                           22. van Rij RP, et al. The RNA silencing endonuclease Argonaute 2 mediates specific antiviral <br />                                               immunity Drosophila melanogaster. Genes Dev. 2006; 20:2985&#226;&#8364;&#8220;2995. [PubMed: 17079687] <br />                                           23. Wang XH, et al. RNA interference directs innate immunity viruses adult Drosophila. <br />                                               Science. 2006; 312:452&#226;&#8364;&#8220;454. [PubMed: 16556799] <br />                                           24. Hahn H, Palmenberg AC. Mutational analysis encephalomyocarditis virus primary cleavage. <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               J Virol. 1996; 70:6870&#226;&#8364;&#8220;6875. [PubMed: 8794329] <br />                                           25. Chapman EJ, Prokhnevsky AI, Gopinath K, Dolja VV, Carrington JC. Viral RNA silencing <br />                                               suppressors inhibit microRNA pathway intermediate step. Genes Dev. 2004; 18:1179&#226;&#8364;&#8220; <br />                                               1186. [PubMed: 15131083] <br />                                           26. Brennecke J, Hipfner DR, Stark A, Russell RB, Cohen SM. bantam encodes developmentally <br />                                               regulated microRNA controls cell proliferation regulates proapoptotic gene hid in <br />                                               Drosophila. Cell. 2003; 113:25&#226;&#8364;&#8220;36. [PubMed: 12679032] <br />                                           27. Roignant JY, et al. Absence transitive systemic pathways allows cell-specific isoform- <br />                                               specific RNAi Drosophila. Rna. 2003; 9:299&#226;&#8364;&#8220;308. [PubMed: 12592004] <br />                                           28. Czech B, et al. An endogenous small interfering RNA pathway Drosophila. Nature. 2008; <br />                                               453:798&#226;&#8364;&#8220;802. [PubMed: 18463631] <br />                                           29. Ghildiyal M, et al. Endogenous siRNAs derived transposons mRNAs Drosophila <br />                                               somatic cells. Science. 2008; 320:1077&#226;&#8364;&#8220;1081. [PubMed: 18403677] <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                                 Page 14 <br />  <br />  <br />                                           30. Kawamura Y, et al. Drosophila endogenous small RNAs bind Argonaute 2 somatic cells. <br />                                               Nature. 2008; 453:793&#226;&#8364;&#8220;797. [PubMed: 18463636] <br />                                           31. Miyoshi K, Tsukumo H, Nagami T, Siomi H, Siomi MC. Slicer function Drosophila Argonautes <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               involvement RISC formation. Genes Dev. 2005; 19:2837&#226;&#8364;&#8220;2848. [PubMed: 16287716] <br />                                           32. Pham JW, Sontheimer EJ. Molecular requirements RNA-induced silencing complex assembly <br />                                               Drosophila <span id='am-162' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-163' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-167' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-168' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-171' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-173' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-177' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-180' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-182' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-185' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-187' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-188' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-190' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-196' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-197' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-203' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-204' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-205' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-208' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-210' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-217' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-219' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-222' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-223' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-225' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-226' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-231' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-233' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-235' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-237' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-238' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-239' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span>RNA interference pathway</span>. J Biol Chem. 2005; 280:39278&#226;&#8364;&#8220;39283. [PubMed: <br />                                               16179342] <br />                                           33. Sontheimer EJ. Assembly function RNA silencing complexes. Nat Rev Mol Cell Biol. <br />                                               2005; 6:127&#226;&#8364;&#8220;138. [PubMed: 15654322] <br />                                           34. Haley B, Tang G, Zamore PD. In vitro analysis RNA interference Drosophila melanogaster. <br />                                               Methods. 2003; 30:330&#226;&#8364;&#8220;336. [PubMed: 12828947] <br />                                           35. Hammond SM, Bernstein E, Beach D, Hannon GJ. An RNA-directed nuclease mediates post- <br />                                               transcriptional gene silencing Drosophila cells. Nature. 2000; 404:293&#226;&#8364;&#8220;296. [PubMed: <br />                                               10749213] <br />                                           36. Thomas-Orillard M, Legendre S. [C virus Drosophila dynamics host population]. C R <br />                                               Acad Sci III. 1996; 319:615&#226;&#8364;&#8220;621. [PubMed: 9011323] <br />                                           37. Plus N, Croizier G, Jousset FX, David J. Picornaviruses laboratory wild Drosophila <br />                                               melanogaster: geographical distribution serotypic composition. Ann Microbiol (Paris). 1975; <br />                                               126:107&#226;&#8364;&#8220;117. [PubMed: 811144] <br />                                           38. Cullen BR. Is RNA interference involved intrinsic antiviral immunity mammals? Nat <br />                                               Immunol. 2006; 7:563&#226;&#8364;&#8220;567. [PubMed: 16715068] <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           39. Mudiganti U, Hernandez R, Ferreira D, Brown DT. Sindbis virus infection model insect cell <br />                                               systems--a comparative study. Virus Res. 2006; 122:28&#226;&#8364;&#8220;34. [PubMed: 16854488] <br />                                           40. Hannon GJ. RNA interference. Nature. 2002; 418:244&#226;&#8364;&#8220;251. [PubMed: 12110901] <br />                                           41. Voinnet O. RNA silencing plant immune viruses. Trends Genet. 2001; 17:449&#226;&#8364;&#8220; <br />                                               459. [PubMed: 11485817] <br />                                           42. Zamore PD. RNA interference: listening sound silence. Nat Struct Biol. 2001; 8:746&#226;&#8364;&#8220;750. <br />                                               [PubMed: 11524674] <br />                                           43. Merai Z, et al. Double-stranded RNA binding general plant RNA viral strategy to <br />                                               suppress RNA silencing. J Virol. 2006; 80:5747&#226;&#8364;&#8220;5756. [PubMed: 16731914] <br />                                           44. Haley B, Zamore PD. Kinetic analysis RNAi enzyme complex. Nat Struct Mol Biol. 2004; <br />                                               11:599&#226;&#8364;&#8220;606. [PubMed: 15170178] <br />                                           45. Vaidyanathan R, Scott TW. Apoptosis mosquito midgut epithelia associated West Nile <br />                                               virus infection. Apoptosis. 2006; 11:1643&#226;&#8364;&#8220;1651. [PubMed: 16820968] <br />                                           46. Horwich MD, Zamore PD. Design delivery antisense oligonucleotides block microRNA <br />                                               function cultured Drosophila human cells. Nat Protoc. 2008; 3:1537&#226;&#8364;&#8220;1549. [PubMed: <br />                                               18802435] <br />                                           47. Blethrow JD, Tang C, Deng C, Krutchinsky AN. Modular mass spectrometric tool analysis of <br />                                               composition phosphorylation protein complexes. PLoS ONE. 2007; 2:e358. [PubMed: <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                               17406682] <br />                                           48. Harper SM, Neil LC, Gardner KH. Structural basis phototropin light switch. Science. 2003; <br />                                               301:1541&#226;&#8364;&#8220;1544. [PubMed: 12970567] <br />                                           49. Ephrussi B, Herold JL. Studies Eye Pigments Drosophila. I. Methods Extraction and <br />                                               Quantitative Estimation Pigment Components. Genetics. 1944; 29:148&#226;&#8364;&#8220;175. [PubMed: <br />                                               17247114] <br />                                           50. Berry B, Deddouche S, Kirschner D, Imler JL, Antoniewski C. Viral suppressors RNA silencing <br />                                               hinder exogenous endogenous small RNA pathways Drosophila. PLoS One. 2009; 4:e5866. <br />                                               [PubMed: 19516905] <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                         Page 15 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 1. <br />                                           Cricket paralysis virus (CrPV) antagonizes RNAi S2 cells. (a) CrPV infected S2 cells or <br />                                           uninfected S2 cells co-transfected firefly, renila luciferase plasmid either <br />                                           double stranded RNA (dsRNA) targeting firefly luciferase (Luc) eGFP dsRNA <br />                                           control (Ctrl). Silencing efficiency S2 cells monitored comparing ratio of <br />                                           firefly renila luciferase expression. (b) CrPV genome encodes non-structural and <br />                                           structural proteins translation regulated internal ribosome entry site (IRES) 1 <br />                                           2 respectively. The extended broken line (&#226;&#710;&#8217;) represents alignment viral suppressor <br />                                           RNA silencing (VSR) domains include N-terminal 180 amino acid CrPV <br />                                           ORF1 111 amino acid DCV ORF1. - indicates gap, * indicates complete <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                         Page 16 <br />  <br />  <br />                                           homology, red open box represents conserved octameric sequence, &#226;&#8224;&#8220; indicates non- <br />                                           proteolytic cleavage site, &#206;&#8221; indicates sites deletion VSR region (c) S2 cells <br />                                           mock (Unif) CrPV infected (at MOI 1) 24hrs 48 hrs. Harvested <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           samples analyzed 1A expression western blot analysis using rabbit polyclonal <br />                                           antibody raised suppressor protein (&#206;&#177;-CrPV-1A). (d) Plasmids encoding C- <br />                                           terminal amino acid deletion putative CrPV suppressor domain (168,148,128,108) were <br />                                           cotransfected dual luciferase reporter FLuc dsRNA targeting firefly <br />                                           luciferase eGFP dsRNA control described figure a. Silencing represented as <br />                                           fold silencing compared control dsRNA. Data (a) (d) indicate averages and <br />                                           standard deviations independent experiments. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                          Page 17 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 2. <br />                                           CrPV-1A potent RNAi suppressor does interfere microRNA pathway. (a) <br />                                           Transgenic flies expressing CrPV-1A148 CrPV-1A108, DCV-1A99 GFP an <br />                                           inverted repeat [IR] directed white gene analyzed ability carry <br />                                           efficient RNAi. Loss red eye pigments presence indicated suppressor proteins is <br />                                           expressed % silencing compared GFP control fly. (b) Transgenic flies expressing <br />                                           CrPV-1A DCV-1A injected intra-thoracically 100 TCID50 DCV Tris <br />                                           buffer control survival rate monitored daily. (c) Luciferase reporter plasmid <br />                                           carrying miR2b target sequences sense antisense orientation (Supplementary Fig. 1b) <br />                                           3&#226;&#8364;&#8482; untranslated region (UTR) transfected S2 cells. Luciferase expression in <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                        Page 18 <br />  <br />  <br />                                           presence CrPV-1A, DCV-1A expressed ratio luciferase counts produced by <br />                                           luciferase miR2b antisense luciferase miR2b sense reporter transfection. (d) S2 cells <br />                                           transfected miR-2b ASO followed trasnsfection reporter (miR2b <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           antisense). miR-2b ASO restored luciferease expression 50% compared Ctrl ASO <br />                                           (e) The effect CrPV-1A bantam mediated translational repression imaginal disc <br />                                           analyzed flies expressing GFP mRNA containing complementary bantam <br />                                           miRNA target sites. (f) Fold changes retrotransposons RNA levels calculated <br />                                           relative 297, mdg1 412 RNA levels measured control flies. Fold changes in <br />                                           homozygous Ago2414 mutants calculated relative heterozygous ago2414 flies. Data <br />                                           (a), (c), (d) (f) indicate standard deviations independent experiments. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                        Page 19 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 3. <br />                                           CrPV-1A inhibits RISC activity downstream Dicer processing. (a) Radio-labeled dsRNA <br />                                           substrates (32P-dsRNA) incubated S2 buffer control (lane 1) S2 extracts (lane <br />                                           2). Processing long dsRNA siRNA Dicer2 presence recombinant CrPV-1A <br />                                           (0.35 &#194;&#181;M, lane 3), DCV-1A (0.35 &#194;&#181;M, lane 5) bovine serum albumin (BSA) (0.35 &#194;&#181;M, <br />                                           lane 4) monitored using 12% denaturing gel end-labeled 21bp synthetic siRNA <br />                                           marker. (b) Recombinant suppressor proteins DCV-1A (0.35 &#194;&#181;M, lane 2), CrPV-1A (0.35 <br />                                           &#194;&#181;M, lane 3) BSA protein (0.35 &#194;&#181;M, lane 4) incubated Drosophila embryo extract <br />                                           10 min. 32P-labeled siRNAs duplex subsequently added reaction another <br />                                           20 min. siRNP complexes (R1, R2 R3) analyzed electrophoretic mobility shift <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                       Page 20 <br />  <br />  <br />                                           assay (EMSA) using 4% native polyacrylamide gel electrophoresis. (c) Target mRNA <br />                                           cleavage assay analyzed absence siRNA (lane 1), presence GAPDH (Ctrl) <br />                                           siRNA (lane 2) Luc siRNA (lane 3-lane 11). To analyze effects CrPV-1A, assays <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           carried using CrPV infected S2 extracts (MOI 1 MOI 2) lane 4, lane 5 by <br />                                           incubating recombinant CrPV-1A increasing concentration (0.15 &#194;&#181;M, lane 6), (0.25 <br />                                           &#194;&#181;M, lane 7), (0.35 &#194;&#181;M, lane 8) uninfected S2 extracts. The activity DCV-1A was <br />                                           analyzed using infected DCV S2 extracts (MOI 1, lane 10) incubating recombinant <br />                                           DCV-1A (0.35 &#194;&#181;M, lane 11) uninfected S2 extracts. The 5&#226;&#8364;&#8482; cleaved products were <br />                                           analyzed denaturing polyacrylamide gel. <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                        Page 21 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 4. <br />                                           CrPV-1A interacts Argonaute 2 S2 cells. (a) S2 cells transfected plasmids <br />                                           transiently expressing CrPV-1A-3FH (lane 2, 4) vector control (lane 1, 3). Flag- <br />                                           His tagged CrPV-1A immunopurified anti-Flag antibody western blotted with <br />                                           Drosophila Argonaute 2 (&#206;&#177;-Ago2, right panel) Argonaute 1 (&#206;&#177;-Ago1, left panel) <br />                                           polyclonal antibodies. Two isoforms Ago2 (Ago2a Ago2b) detected Ago2 <br />                                           specific antibodies. Asterisks (*) indicate cross-reacting host-protein band. Lane 6 8 <br />                                           positive detection E.coli expressed Drosophila Ago1 endogenous <br />                                           Drosophila Ago2 Ago1 Ago2 antibody respectively (Ab control). (b) Flag-His <br />                                           tagged CrPV-1A148, CrPV-1A108 transfected S2 cells, immunopurified using <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                         Page 22 <br />  <br />  <br />                                           anti-Flag antibody probed Ago2 antibody (&#206;&#177;-Ago2). To detect expression of <br />                                           1A protein, blot stripped probed anti-Flag antibody (&#206;&#177;-Flag) (lane 3 <br />                                           lane 4, panel). Asterisks (*) indicates cross-reacting host-protein band (c) <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Stable S2 cell lines expressing CrPV-1A-3FH (induced CuSO4) uninduced <br />                                           control lysed, immunopurified anti-Flag antibody followed Talon magnetic <br />                                           bead purification. The silver stained gel shows co-purification CrPV-1A and <br />                                           Argonaute 2 (Ago2b isoform) S2 cells (right lane). Left lane represents molecular <br />                                           weight marker. Asterisk (*) indicates non-specific contaminant band (see Supplementary <br />                                           figure 3). <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Nat Struct Mol Biol. Author manuscript; available PMC 2013 November 03. <br />                             Nayak et al.                                                                                       Page 23 <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br /> NIH-PA Author Manuscript <br />  <br />  <br />  <br />  <br />                                           Figure 5. <br />                                           CrPV-1A interferes function pre-programmed holo-RISC vitro vivo. (a) <br />                                           S2 extracts programmed siRNA 45 min followed addition 1A [(0.35 &#194;&#181;M <br />                                           CrPV-1A, lane 3), (0.35 &#194;&#181;M DCV-1A, lane 4) (BSA, lane 5)] 10 min. RISC assay was <br />                                           initiated incubating 32P-mRNA substrate additional 3hrs 5&#226;&#8364;&#178; cleaved product was <br />                                           analyzed using denaturing polyacrylamide gel electrophorsis (PAGE). (b) Silencing of <br />                                           firefly luciferase stable S2 cells programmed co-transfec <br /> </body></html>